Prevalence of osteosarcopenia in postmenopausal women: a systematic review and meta-analysis.
J Endocrinol InvestJun 8, 2026 (epub)
Ke-Qin Yu, Tian-Tian Ye, Wei-Qiang Zhao
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis assessed the prevalence of osteosarcopenia (OSP) in postmenopausal women, analyzing data from 16 studies involving 7,631 participants. The pooled prevalence of OSP was found to be 15.6% (95% CI: 9.6-24.3%). The study highlights significant variability in prevalence based on geographic and demographic factors.
Key findings
- The pooled prevalence of osteosarcopenia in postmenopausal women was 15.6% (95% CI: 9.6-24.3%).
- Prevalence was higher in developing regions at 18.0% compared to 12.7% in developed regions.
- Asian countries showed a prevalence of 18.7%, while non-Asian countries had 8.2%.
- Hospital-based populations had a prevalence of 26.4%, compared to 8.7% in community-based populations.
Why it matters
Understanding the prevalence of osteosarcopenia in postmenopausal women is crucial for identifying at-risk individuals and implementing preventive strategies. This condition increases the risk of falls, fractures, and frailty, impacting overall health and quality of life.